Big Moving Stock chart patterns and volume.

Nasdaq: GOOG NFLX BIIB IBB AMZN TSLA ILMN ALXN AMGN WYNN COST SLXP GMCR CELG SBAC AAPL VRTX FFIV GILD
Nyse: ACT V AGN SPG IVV PCP LMT GS FDX MMM NOC IBM BA APD PXD CMI BDX TWC ANTM GD
New Highs: NOC BA PANW HAR HD VAR SWKS TSCO KRC NOW VMC ALK MD SCG PCG AWK BC EA BR LUV

The Hot Industries

Regional Airlines 2
Electric Utilities 2
Specialized Health Services 1

The Hot Sectors

Technology 5
Services 4
Industrial Goods 3

Social Buzz

JNJ is headed higher?

JNJ Stock ChartSimilar Stocks: PFE SYK GILD RHHB MDT NVS IART


JNJ
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Major
Weekly

Employees:

128,100
Monthly

Website:

http://www.jnj.com

JNJ Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

favicon

Health Care Sector Update for 01/28/2015: CBLI,ABMD,AGIO

28 Jan 2015, 2:29 pmHealth Care Sector Update for 01/28/2015: CBLI,ABMD,AGIO
favicon

Interesting January 2017 Stock Options for Johnson & Johnson

26 Jan 2015, 11:31 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.
favicon

Johnson & Johnson (JNJ) Stock Falls Today After Lowering 2015 Earnings Forecast

20 Jan 2015, 8:29 amNEW YORK (TheStreet) -- Shares of Johnson & Johnson , the world's biggest maker of health-care products, are down 3.14% to $100.77 after the company forecast lower earnings in 2015 as competition cuts into revenue for some of its best-selling drugs, Bloomberg reports. The company announced adjusted earnings guidance for full year 2015 of $6.12 to $6.27 per share. After-tax intangible ...
favicon

J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues - Tale of the Tape

20 Jan 2015, 7:00 amJ&J (JNJ) Beats on 4Q Earnings but Misses on Revenues
favicon

Pre-Market Earnings Report for January 20, 2015 : JNJ, MS, DAL, HAL, BHI, MTB, RF, IGTE, ATI, EDU, MTG, SAP

16 Jan 2015, 2:19 pmPre-Market Earnings Report for January 20, 2015 : JNJ, MS, DAL, HAL, BHI, MTB, RF, IGTE, ATI, EDU, MTG, SAP
favicon

Johnson & Johnson (JNJ) Stock Lower Today After Goldman Downgrade

15 Jan 2015, 7:14 amNEW YORK (TheStreet) -- Shares of Johnson & Johnson  are down 0.78% to $103.19 in pre-market trading after Goldman Sachs downgraded the company to "sell" from "neutral" while maintaining its $97 price target. "The Pharma business unit has driven outperformance of JNJ shares ever since delivering double digit growth starting in 1Q13. New drug launches such as Zytiga, Xarelto, Stelara, Invokana ...
favicon

Call selling hits JNJ before earnings

13 Jan 2015, 11:18 amJohnson & Johnson is seeing huge call selling ahead of its earnings report next week. optionMONSTER systems show that more than 65,000 April 110 calls have changed hands today, almost all of them in blocks ...
favicon

Interesting February Stock Options for Johnson & Johnson

12 Jan 2015, 10:15 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the February expiration for JNJ.
favicon

Interesting March Stock Options for Johnson & Johnson

5 Jan 2015, 10:59 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the March expiration for JNJ.
favicon

February 2015 Options Now Available For Johnson & Johnson

31 Dec 2014, 9:35 amFebruary 2015 Options Now Available For Johnson & Johnson